Deborah A. Nicoll‐Griffith
Papers
1
Total Citations
51
H-Index
1
About
Deborah A. Nicoll‐Griffith is a pioneering figure in preclinical pharmacokinetics and bioanalytical methodology, best known for her transformative work in reducing animal usage in drug development. Her landmark 2001 study, cited 51 times, introduced a groundbreaking approach that combined serial bleeding of mice with robotic sample preparation and fast liquid chromatography–mass spectrometry. This innovation not only minimized the number of animals required for pharmacokinetic studies but also enhanced the efficiency and accuracy of drug metabolism assessments. By demonstrating that robust pharmacokinetic data could be obtained from a single mouse over time, Nicoll‐Griffith directly addressed ethical and practical challenges in pharmaceutical research. Her work has had a lasting impact on the field, influencing protocols for high-throughput bioanalysis and advancing the principles of the 3Rs (Replacement, Reduction, Refinement) in animal research. A respected contributor to drug discovery and development, she remains a key reference for researchers seeking to balance rigorous scientific inquiry with humane experimental design.
Research Focus
Key Achievements
Top Papers
- 1